2/13/2025 EU’s Urban Wastewater Treatment Directive could lead to additional costs of nearly EUR 1 billion in Finland alone, posing a serious threat to medicine availability All releases Translating world-class science into novel life-changing therapies Orion’s pharmaceutical R&D focuses on...
Our teams operate in Finland, Sweden, Norway, Denmark, Belgium, France, Poland, Hungary, Czech Republic, Slovakia, Romania, Lithuania, Latvia, Estonia and Vietnam. In these countries we operate through partners. About us At Orion Pharma Animal Health, we’re committed to the well-being of al...
Animal Health’s offices span across Europe, with our headquarters located in Espoo, Finland. We operate in six continents and have sales organisations in several countries. Our teams operate in Finland, Sweden, Norway, Denmark, Belgium, France, Poland, Hungary, Czech Republic, Slovakia, Romania,...
商标名称 ORION PHARMA 国际分类 第05类-医药 商标状态 驳回复审 申请/注册号 44041385 申请日期 2020-02-11 申请人名称(中文) 奥仁公司;ORIONCORPORATION 申请人名称(英文) - 申请人地址(中文) 芬兰爱斯埔02200,奥瑞奈梯1;ORIONINTIE 1,02200 ESPOO,FINLAND 申请人地址(英文) - 初审公告期号 - 初审公告日期...
Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland http://www.orionpharma.com Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterin...
Orionintie 1A, FI-02200 Espoo, Finland http://www.orionpharma.com Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical...
Communications Orionintie 1A, FI-02200 Espoo, Finland http://www.orionpharma.com Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredien...
Finland SUPPORT AND INQUIRIES (FINNISH OR ENGLISH): toxbuddy@orionpharma.com Tel. +358 10 426 4906 Mon-Fri 10-11 am (Finnish time) 9-10 am (Central European time) Login Privacy policy Terms of use Cookie policy DOWNLOAD GUIDE Psst! Subscribe at once to our ToxBuddynewsletterto stay updat...
STOCKHOLM,Aug. 18, 2021/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based inFinland...
Contact person:Tuukka Hirvonen,Investor Relations,Orion Corporationtel. +358 10 426 2721 Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200Espoo, Finlandwww.orionpharma.com Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundr...